advancing innovation to save lives

A Pipeline of Promise: The Global Health Research and Development Process

Check out our interactive infographic to learn more about the global health R&D process and challenges that arise along the development pipeline.
Learn More

R&D Facts

Be in the know. Discover important facts and figures about global health research and development on our R&D Facts page.
Learn More

Infectious Diseases Society of America

IDSA’s blog Science Speaks offers the latest news and analysis on global infectious disease policy, science, research, and development.  Click to read Science Speaks’ analysis of the 115th Congress and the Presidential transition.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.

Learn more
GHTC issues statement on CEWG follow-up, R&D observatory at WHO Executive board meeting

GHTC issued a statement at the 140th session of the World Health Organization (WHO) Executive Board welcoming progress by WHO in operationalizing a Global Observatory on Health Research and Development as a follow-up to the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG). The statement, which was issued in partnership with the Global Health Council, also encouraged member states to fully fund the observatory and recommended diverse global health stakeholders be consulted as the process moves forward.

PDF
GHTC issues statement on antimicrobial resistance at WHO Executive Board meeting

GHTC issued a statement at the 140th session of the World Health Organization (WHO) Executive Board supporting the assembly’s resolution on antimicrobial resistance (AMR), which incorporates R&D as a vital part of WHO’s strategy to combat AMR. The statement also calls for WHO to accelerate efforts to develop accountability frameworks to ensure AMR commitments are realized. The statement was issued in partnership with the Global Health Council and PATH.

PDF
View All News & Events

Member Event

PATH/Doune Porter
Community Discussion on the Reinstatement of the Mexico City Policy
Global Health Council
Learn More

Member Event

Global Health Council
The Future of Global Health 2017
Global Health Council
Learn More
View All Events
CDC/James Gathany
Research Roundup: Bacteria-sniffing dogs, vaccines for epidemics, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
GHTC
The world keeps turning: WHO’s 140th Executive Board meeting begins

With the 140th World Health Organization Executive Board meeting commencing this week, GHTC takes a look at what's on the agenda and how it could impact global health R&D.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide